Showing results (441-450 of 3,523) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|September 2, 2022
Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapyTakanori Abe, Misaki Iino, Satoshi Saito, et al.
Thoracic Cancer|December 28, 2021
Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancerMengqing Xie, Xin Yu, Xiangling Chu, et al.
Thoracic Cancer|November 4, 2022
Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?Yoshitaka Ono, Naoki Hayama, Shigeaki Hattori, et al.
Thoracic Cancer|November 28, 2023
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study)Ou Yamaguchi, Keita Mori, Saori Takata, et al.
Thoracic Cancer|November 22, 2023
Circ_0020123 promotes non-small cell lung cancer progression via miR-146a-5p mediated regulation of EIF4G2 expressionZichun Wei, Jixian Liu, Gang Hui, et al.
Thoracic Cancer|January 10, 2024
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma"Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, et al.
Thoracic Cancer|January 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancerGen Lin, Zhijie Wang, Qian Chu, et al.
Thoracic Cancer|January 7, 2024
Pathological characteristics of lung tumors in Sri Lanka 2017-2021Yasith Mathangasinghe, Sameera Wijayawardhana, Udeshika Perera, et al.
Thoracic Cancer|January 12, 2024
Causal effects of gut microbiota in the development of lung cancer and its histological subtypes: A Mendelian randomization studyYunlei Ma, Yuqing Deng, Tingting Shao, et al.
Thoracic Cancer|January 3, 2024
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South KoreaDa Som Jeon, Cheol-Kyu Park, Seung Joon Kim, et al.
Pageof 353